{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:10:42Z","timestamp":1793293842588,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2022ZFJH003"],"award-info":[{"award-number":["2022ZFJH003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Central Guidance Fund for Local Science and Technology Development","award":["2024ZY01054"],"award-info":[{"award-number":["2024ZY01054"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease characterized by leukopenia and thrombocytopenia, and aspergillosis is a common complication in severe cases. Previous studies have reported cases of SFTS complicated with invasive pulmonary aspergillosis (IPA) and central nervous system aspergillosis. Here, we present the first case of an immunocompetent patient with SFTS who progressed to IPA and <jats:italic>Aspergillus<\/jats:italic> endocarditis after glucocorticoid treatment, and embolism of the vegetations from the left ventricle led to multiple infarctions in the brain, kidney, and spleen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 66-year-old male farmer developed altered mental status during SFTS. His consciousness improved during the treatment of glucocorticoids, intravenous immunoglobulin, and ribavirin, but he developed embolisms in the spleen and right kidney, initially attributed to atrial fibrillation, and the anticoagulant agent was not administered due to the high risk of bleeding. Later, He was diagnosed with SFTS-associated IPA (SAPA), for which voriconazole was administered. However, he subsequently experienced a recurrence of altered mental status, accompanied by headache, blindness, and muscle weakness. Brain magnetic resonance imaging (MRI) revealed multiple cerebral embolisms and abscess. The echocardiography showed the vegetations in the left ventricle, suggesting multi-organ embolism caused by infective endocarditis (IE). <jats:italic>Aspergillus fumigatus<\/jats:italic> was confirmed through pathology and culture of the excised vegetations. The patient was eventually discharged with improved consciousness and muscle strength, but his vision showed minimal recovery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Clinicians should be wary of aspergillosis in severe patients with SFTS, particularly those receiving glucocorticoid treatment. In patients with SAPA, cerebral aspergillosis and embolic stroke caused by <jats:italic>Aspergillus<\/jats:italic> endocarditis should also be considered when mental status alters. Furthermore, the possibility of Aspergillosis in other organs should be considered in high-risk patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-10503-7","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T10:28:13Z","timestamp":1737714493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Severe fever with thrombocytopenia syndrome complicated with aspergillus endocarditis and multiple organ infarctions after glucocorticoid treatment in an immunocompetent man: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuxi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"16","key":"10503_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","volume":"364","author":"X-J Yu","year":"2011","unstructured":"Yu X-J, Liang M-F, Zhang S-Y, Liu Y, Li J-D, Sun Y-L, Zhang L, Zhang Q-F, Popov VL, Li C, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364(16):1523\u201332.","journal-title":"N Engl J Med"},{"issue":"5","key":"10503_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s12276-021-00610-1","volume":"53","author":"MA Casel","year":"2021","unstructured":"Casel MA, Park SJ, Choi YK. Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy. Exp Mol Med. 2021;53(5):713\u201322.","journal-title":"Exp Mol Med"},{"key":"10503_CR3","doi-asserted-by":"crossref","unstructured":"Park SY, Kwon JS, Kim JY, Kim SM, Jang YR, Kim MC, Cho OH, Kim T, Chong YP, Lee SO et al. Severe fever with thrombocytopenia syndrome-associated encephalopathy\/encephalitis. Clin Microbiol Infect 2018, 24(4):432.e431-432.e434.","DOI":"10.1016\/j.cmi.2017.09.002"},{"issue":"5","key":"10503_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jiac.2023.01.014","volume":"29","author":"X Youdong","year":"2023","unstructured":"Youdong X, Xiaofeng D, Xiyuan N, Zhengdong L. Analysis of the risk factors and prognosis for severe fever with thrombocytopenia syndrome associated encephalopathy. J Infect Chemother. 2023;29(5):464\u20138.","journal-title":"J Infect Chemother"},{"issue":"1","key":"10503_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jinf.2014.08.001","volume":"70","author":"N Cui","year":"2015","unstructured":"Cui N, Liu R, Lu Q-B, Wang L-Y, Qin S-L, Yang Z-D, Zhuang L, Liu K, Li H, Zhang X-A, et al. Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis. J Infect. 2015;70(1):52\u20139.","journal-title":"J Infect"},{"issue":"12","key":"10503_CR6","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.1002\/jmv.28059","volume":"94","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Huang Y, Xu Y. Associated Microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections. J Med Virol. 2022;94(12):5916\u201321.","journal-title":"J Med Virol"},{"key":"10503_CR7","doi-asserted-by":"publisher","first-page":"1298050","DOI":"10.3389\/fcimb.2023.1298050","volume":"13","author":"H Song","year":"2023","unstructured":"Song H, Zou S, Huang Y, Wang Y, Wang T, Wei W, Sun Z, Hou H. The pathogenic and clinical characteristics of severe fever with thrombocytopenia syndrome patients with co-infections. Front Cell Infect Microbiol. 2023;13:1298050.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10503_CR8","doi-asserted-by":"publisher","first-page":"e29647","DOI":"10.1002\/jmv.29647","volume":"96","author":"L Yao","year":"2024","unstructured":"Yao L, Shi Y, Fu J, Fang X, Zhang H, Luo D, Zhou Y, Pan A, Yu Y, Yang X, et al. Risk factors for invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome: a multicenter retrospective study. J Med Virol. 2024;96(5):e29647.","journal-title":"J Med Virol"},{"issue":"4","key":"10503_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1\u201360.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10503_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jiac.2018.01.005","volume":"24","author":"X Chen","year":"2018","unstructured":"Chen X, Yu Z, Qian Y, Dong D, Hao Y, Liu N, Gu Q. Clinical features of fatal severe fever with thrombocytopenia syndrome that is complicated by invasive pulmonary aspergillosis. J Infect Chemother. 2018;24(6):422\u20137.","journal-title":"J Infect Chemother"},{"issue":"9","key":"10503_CR11","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/myc.13274","volume":"64","author":"JD Jenks","year":"2021","unstructured":"Jenks JD, Nam HH, Hoenigl M. Invasive aspergillosis in critically ill patients: review of definitions and diagnostic approaches. Mycoses. 2021;64(9):1002\u201314.","journal-title":"Mycoses"},{"issue":"1","key":"10503_CR12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/s12879-021-06627-1","volume":"21","author":"Y Xu","year":"2021","unstructured":"Xu Y, Shao M, Liu N, Dong D, Tang J, Gu Q. Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis\/encephalopathy: a retrospective study. BMC Infect Dis. 2021;21(1):904.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10503_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jiac.2017.11.004","volume":"24","author":"S Nakamura","year":"2018","unstructured":"Nakamura S, Azuma M, Maruhashi T, Sogabe K, Sumitani R, Uemura M, Iwasa M, Fujii S, Miki H, Kagawa K, et al. Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome. J Infect Chemother. 2018;24(5):389\u201392.","journal-title":"J Infect Chemother"},{"issue":"7","key":"10503_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3851\/IMP3036","volume":"21","author":"UJ Kim","year":"2016","unstructured":"Kim UJ, Kim D-M, Ahn JH, Kang S-J, Jang H-C, Park K-H, Jung SI. Successful treatment of rapidly progressing severe fever with thrombocytopenia syndrome with neurological complications using intravenous immunoglobulin and corticosteroid. Antivir Ther. 2016;21(7):637\u201340.","journal-title":"Antivir Ther"},{"key":"10503_CR15","doi-asserted-by":"publisher","first-page":"1209705","DOI":"10.3389\/fmicb.2023.1209705","volume":"14","author":"Y Dai","year":"2023","unstructured":"Dai Y, Pu Q, Hu N, Zhu J, Han Y, Shi P, Li J, Jin K. The dose-response relationship between smoking and the risk factor for invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome. Front Microbiol. 2023;14:1209705.","journal-title":"Front Microbiol"},{"key":"10503_CR16","doi-asserted-by":"publisher","first-page":"1419015","DOI":"10.3389\/fcimb.2024.1419015","volume":"14","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang H, Zhou F, Guo C. The use of glucocorticoid in severe fever with thrombocytopenia syndrome: a retrospective cohort study. Front Cell Infect Microbiol. 2024;14:1419015.","journal-title":"Front Cell Infect Microbiol"},{"key":"10503_CR17","doi-asserted-by":"publisher","first-page":"104807","DOI":"10.1016\/j.ebiom.2023.104807","volume":"96","author":"S-S Zhang","year":"2023","unstructured":"Zhang S-S, Du J, Cui N, Yang X, Zhang L, Zhang W-X, Yue M, Wu Y-X, Yang T, Zhang X-A, et al. Clinical efficacy of immunoglobulin on the treatment of severe fever with thrombocytopenia syndrome: a retrospective cohort study. EBioMedicine. 2023;96:104807.","journal-title":"EBioMedicine"},{"issue":"1","key":"10503_CR18","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1038\/s41467-018-05746-9","volume":"9","author":"P Song","year":"2018","unstructured":"Song P, Zheng N, Liu Y, Tian C, Wu X, Ma X, Chen D, Zou X, Wang G, Wang H, et al. Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection. Nat Commun. 2018;9(1):3328.","journal-title":"Nat Commun"},{"issue":"8","key":"10503_CR19","doi-asserted-by":"publisher","first-page":"110039","DOI":"10.1016\/j.celrep.2021.110039","volume":"37","author":"H Li","year":"2021","unstructured":"Li H, Li X, Lv S, Peng X, Cui N, Yang T, Yang Z, Yuan C, Yuan Y, Yao J, et al. Single-cell landscape of peripheral immune responses to fatal SFTS. Cell Rep. 2021;37(8):110039.","journal-title":"Cell Rep"},{"key":"10503_CR20","doi-asserted-by":"crossref","unstructured":"Latg\u00e9 J-P, Chamilos G. Aspergillus Fumigatus and aspergillosis in 2019. Clin Microbiol Rev 2019, 33(1).","DOI":"10.1128\/CMR.00140-18"},{"issue":"1","key":"10503_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12916-024-03421-z","volume":"22","author":"S Wen","year":"2024","unstructured":"Wen S, Xu N, Zhao L, Yang L, Yang H, Chang C, Wang S, Qu C, Song L, Zou W, et al. Ruxolitinib plus standard of care in severe hospitalized adults with severe fever with thrombocytopenia syndrome (SFTS): an exploratory, single-arm trial. BMC Med. 2024;22(1):204.","journal-title":"BMC Med"},{"issue":"1","key":"10503_CR22","doi-asserted-by":"publisher","first-page":"106181","DOI":"10.1016\/j.jinf.2024.106181","volume":"89","author":"H-H Ge","year":"2024","unstructured":"Ge H-H, Cui N, Yin X-H, Hu L-F, Wang Z-Y, Yuan Y-M, Yue M, Lv H-D, Wang Z, Zhang W-W, et al. Effect of tocilizumab plus corticosteroid on clinical outcome in patients hospitalized with severe fever with thrombocytopenia syndrome: a randomized clinical trial. J Infect. 2024;89(1):106181.","journal-title":"J Infect"},{"issue":"7","key":"10503_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/myc.13451","volume":"65","author":"J Forster","year":"2022","unstructured":"Forster J, Hoenigl M, Suerbaum S, Wagener J, Dichtl K. Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: a comparison of galactomannan, mannan and \u03b2-1,3-D-gucan testing from serum and cerebrospinal fluid. Mycoses. 2022;65(7):709\u201314.","journal-title":"Mycoses"},{"issue":"8","key":"10503_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.idnow.2021.04.002","volume":"51","author":"DS Meena","year":"2021","unstructured":"Meena DS, Kumar D, Bohra GK, Kumar G. Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: a systematic review of 235 cases. Infect Dis Now. 2021;51(8):654\u201360.","journal-title":"Infect Dis Now"},{"key":"10503_CR25","doi-asserted-by":"publisher","first-page":"117325","DOI":"10.1016\/j.jns.2021.117325","volume":"422","author":"CL Nathan","year":"2021","unstructured":"Nathan CL, Emmert BE, Nelson E, Berger JR. CNS fungal infections: a review. J Neurol Sci. 2021;422:117325.","journal-title":"J Neurol Sci"},{"issue":"2","key":"10503_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jinf.2021.11.014","volume":"84","author":"A Serris","year":"2022","unstructured":"Serris A, Benzakoun J, Danion F, Porcher R, Sonneville R, Wolff M, Kremer S, Letscher-Bru V, Fekkar A, Hekimian G, et al. Cerebral aspergillosis in the era of new antifungals: the CEREALS national cohort study Nationwide CEREbral aspergillosis Lesional study (CEREALS). J Infect. 2022;84(2):227\u201336.","journal-title":"J Infect"},{"key":"10503_CR27","doi-asserted-by":"crossref","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Fl\u00f6rl C, Lewis RE, Munoz P, Verweij PE et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 2018, 24 Suppl 1.","DOI":"10.1016\/j.cmi.2018.01.002"},{"issue":"4","key":"10503_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/cid\/ciad271","volume":"77","author":"VG Fowler","year":"2023","unstructured":"Fowler VG, Durack DT, Selton-Suty C, Athan E, Bayer AS, Chamis AL, Dahl A, DiBernardo L, Durante-Mangoni E, Duval X, et al. The 2023 Duke-International Society for Cardiovascular Infectious diseases Criteria for Infective endocarditis: updating the modified Duke Criteria. Clin Infect Dis. 2023;77(4):518\u201326.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10503_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s13256-023-04252-x","volume":"17","author":"Z Yassin","year":"2023","unstructured":"Yassin Z, Hajsadeghi S, Shavazi MT, Fattahi M, Ahmadzadeh K, Farid A, Karimi Y, Seirafianpour F, Babaheidarian P, Goodarzi A. Endocarditis caused by aspergillus fumigatus in a patient 9 months after COVID-19 infection recovery: a case report and review of the literature. J Med Case Rep. 2023;17(1):519.","journal-title":"J Med Case Rep"},{"key":"10503_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.12659\/AJCR.892428","volume":"16","author":"T Demir","year":"2015","unstructured":"Demir T, Ergenoglu MU, Ekinci A, Tanrikulu N, Sahin M, Demirsoy E. Aspergillus flavus endocarditis of the native mitral valve in a bone marrow transplant patient. Am J Case Rep. 2015;16:25\u201330.","journal-title":"Am J Case Rep"},{"issue":"3","key":"10503_CR31","doi-asserted-by":"publisher","first-page":"e0001923","DOI":"10.1128\/cmr.00019-23","volume":"36","author":"GR Thompson","year":"2023","unstructured":"Thompson GR, Jenks JD, Baddley JW, Lewis JS, Egger M, Schwartz IS, Boyer J, Patterson TF, Chen SCA, Pappas PG, et al. Fungal endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management. Clin Microbiol Rev. 2023;36(3):e0001923.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10503_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/myc.13398","volume":"65","author":"DS Meena","year":"2022","unstructured":"Meena DS, Kumar D, Agarwal M, Bohra GK, Choudhary R, Samantaray S, Sharma S, Midha N, Garg MK. Clinical features, diagnosis and treatment outcome of fungal endocarditis: a systematic review of reported cases. Mycoses. 2022;65(3):294\u2013302.","journal-title":"Mycoses"},{"issue":"11","key":"10503_CR33","doi-asserted-by":"publisher","first-page":"ofad509","DOI":"10.1093\/ofid\/ofad509","volume":"10","author":"Q Liu","year":"2023","unstructured":"Liu Q, Yang M, Shen S, Gong C, Lan Z. Cardiac abnormalities in patients with severe fever with Thrombocytopenia Syndrome: a systematic review. Open Forum Infect Dis. 2023;10(11):ofad509.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10503_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"issue":"3","key":"10503_CR35","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/clc.23554","volume":"44","author":"W Hu","year":"2021","unstructured":"Hu W, Wang X, Su G. Infective endocarditis complicated by embolic events: Pathogenesis and predictors. Clin Cardiol. 2021;44(3):307\u201315.","journal-title":"Clin Cardiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10503-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T10:28:19Z","timestamp":1737714499000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10503-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10503"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10503-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (IIT20240906A). Written informed consent was obtained from the patient for the publication of personal and clinical details along with any potentially identifiable images included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of the report and accompanying images. All authors agreed to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}